Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Suppressing ODC activity reduces tumor growth in hair follicles.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.